Elevated HBXIP expression is associated with aggressive phenotype and poor prognosis in esophageal squamous cell carcinoma.
Year: 2017
Type: article
Study design: Observational Study
Abstract: =0.002). Kaplan-Meier analysis indicated that ESCC patients with high HBXIP expression had poor disease-free survival (DFS) and overall survival (OS). Furthermore, multivariate Cox regression analyses demonstrated that HBXIP expression remained an independent prognostic factor for DFS and OS. Collectively, our present study demonstrated that HBXIP may be a candidate molecular prognostic marker for ESCC.
Source: Europe PMC (PubMed Central)
Authors: Honggang Xia, Lan Ma, Jing Li, Hongyu Bai, Dongbin Wang
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2982279904
